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Abstract— Support Vector Machine (SVM) is a machine learning method and widely used in the area of cancer studies especially in 
microarray data. A common problem related to the microarray data is that the size of genes is essentially larger than the number of 
samples. Although SVM is capable of handling a large number of genes, better accuracy of classification can be obtained using a 
small number of gene subset. This research proposed Multiple Support Vector Machine- Recursive Feature Elimination (MSVM-
RFE) as a gene selection to identify the small number of informative genes. This method is implemented in order to improve the 
performance of SVM during classification. The effectiveness of the proposed method has been tested on two different datasets of gene 
expression which are leukemia and lung cancer. In order to see the effectiveness of the proposed method, some methods such as 
Random Forest and C4.5 Decision Tree are compared in this paper. The result shows that this MSVM-RFE is effective in reducing 
the number of genes in both datasets thus providing a better accuracy for SVM in cancer classification. 
 





Cancer or called as malignancy is a group of disease 
involving uncontrolled and abnormal cell growth [1]. 
Furthermore, cancer is one of the main cause of death in this 
world. However, not all of uncontrolled and abnormal cell 
growths are cancerous, it all depends on the number of 
active and inactive cell in it. There are more than one 
hundred types of cancer such as skin cancer, breast cancer, 
leukemia, prostate cancer and other. Presently, in the field of 
medical, the major research is in the area of cancer analysis 
where there is a demand in developing a powerful method 
for the purpose of a cancer diagnosis.  
Customarily, physical analyses of tissues are performed 
for cancer or tumour prognosis and diagnosis utilizing 
Computed Tomography (CT) scan, Chest X-ray, and 
Magnetic Resonance Imaging (MRI) [2], [3]. However, they 
can only identify the malignant cells in the late stage of 
cancer and would bring about low survival rates [4]. Thus, 
the studying of cancer to identify the formation of tumour at 
the earlier stage propels in molecular biologies such as DNA, 
protein, and RNA was proposed. However, as that review 
was investigated and examined utilizing low-throughput 
information, prior knowledge of disease is required for 
securing the information of candidate markers. Moreover, 
there is a limitation in finding the novel markers which is 
caused by the presence of an only small number of markers 
[5].  
Therefore, microarray method is presented. In Gordon et 
al., [6] has investigated the cancer diagnosis method based 
on gene expression and showed the best performance in the 
accuracy of classification. The usefulness of the microarray 
data has motivated many researchers to perform large-scale 
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area of this study. The era of microarray technologies for 
measuring genome-wide expression profiles has prompted 
the development and improvement of various methods and 
techniques to distinguish between different classes of a 
complex disease like cancer through transcriptome analysis 
[7]–[10]. Besides, many of classification methods such as 
Support Vector Machine (SVM) [11], Directed Random 
Walk (DRW) [12] and Artificial Neural Network (ANN) [13] 
have been developed to help this era. Fig. 1 shows the 
visualization of the process in the microarray analysis. 
 
 
Fig. 1  Visualization of the process in microarray analysis 
 
However, the preparation of microarray data is a critical 
step in biological function analyses, especially in cancer 
classification. The microarray data will produce a huge 
dataset with high dimensionality that contains informative 
genes, redundant genes, irrelevant genes, and noisy genes. 
Gene selection is a method to alleviate the problems of the 
irrelevant or redundant gene. 
The pure Support Vector Machines (SVM) is also known 
as support vector network. It is one of the machine learning 
models that introduced by Vapnik [14]. Furthermore, it is a 
machine learning model with a related algorithm that 
analyzes the data and identifies the pattern of the data. It is 
used for the classification and regression analysis [11]. An 
SVM model is a representation data as a point in the space. 
It will construct the hyperplane on the map to classify the 
data and predict the group based on which side of the gap 
it’s fall on such as in Fig. 2. Using the kernel trick, it can 
handle and effectively perform non-linear classification. It 
has four types of kernel, i.e., linear, polynomial, radial basis 
function (RBF) and sigmoid. 
Besides, it is robust to a high variable-to-test degree and a 
huge number of variables, able to learn productively 
complex classification function, and manage to utilize 
intense regularization standards to abstain from overfitting 
[14]-[17]. It is broadly utilized as a part of the area of cancer 
studies and commonly in microarray data [24]–[26], [18]-
[20]. 
Regrettably, the size of features or genes in microarray 
data is essentially bigger than the number of samples. In any 
case, the scantiness of a microarrays gene expression is so 
compelling that even an SVM classifier is unable to 
accomplish a palatable performance. Thus, the preprocessing 
step of gene selection or feature selection before undergoing 
the classification is vital for more trustworthy cancer 
classification [27], [21].  
 
 
Fig. 2  The example of Linear-SVM-scatterplot 
II. MATERIAL AND METHOD 
A. Multiple Support Vector Machine Recursive Feature 
Elimination (MSVM-RFE) 
Currently, most of the microarray data for the cancer 
classification generated bewildering amounts of raw data, 
and the number of genes is larger than the number of 
samples. To secure against spurious results, gene selection is 
a better solution to solve the vital machine learning problem. 
Identifying a small number of informative genes is the 
objective of gene selection. Many evolutions had been made 
in the Support Vector Machine- Recursive Elimination 
(SVM-RFE), from the basic of SVM-RFE to two-stage 
SVM-RFE and multiple SVM-RFE. 
Reducing the dimensionality of the dataset will yield a 
good analysis [24], [18]. Multiple SVM-RFE (MSVM-RFE) 
[28], [22] is an upgraded version of the original SVM-RFE. 
MSVM stand for multiple SVMs that use a backward 
elimination procedure to eliminate the lowest weight of the 
gene, similar to the SVM-RFE. However, at each step, the 
computation of feature ranking score is based on the 
statistical analysis of weight vector of multiple linear SVMs 
that being trained on a subset of the training data. This 
approach makes the result of MSVM-RFE to be better and 
more accurate compared to the SVM-RFE. 
Furthermore, repeating the selection procedure on a few 
subsamples from bootstrap resampling on the training data is 
one of the ways to stabilize the gene selection method. This 
idea is applied to every step of recursive MSVM-RFE, rather 
than apply this idea on SVM-RFE all in all. Moreover, 
MSVM-RFE also used cross-validation instead of bootstrap 
sampling as the resampling method explores the higher 
possibility of choosing and determining a better subset of the 
gene in the recursive procedure. Hence, MSVM-RFE is a 
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meaningful and powerful approach in gene selection to 
select the informative genes for cancer classification.  Based 
on these reasons, the MSVM-RFE has been chosen for the 
purpose of gene selection in this research to enhance SVM.  
In order to train on different subsamples of original 
training data, we have 	linear SVMs. The   is a weight 
vector of the th linear SVMs,   is a corresponding weight 
value associated with the th feature and let   =	
. The 
score of feature ranking is computed with the following 
formula: 
 
                                         (1) 
 





 	                          (3)    
 
where   is mean and   is a standard deviation for the  , 
However it is important to normalize the weight vectors 
before computed the ranking score for each gene. 
 
 	 !"!"                           (4) 
 
The procedure of MSVM-RFE start with ranking the gene 
set, R = [ ]. From a selected gene subset of S = [1,…,d], the 
following step is repeated until all the features or genes are 
ranked. Firstly, the multiple linear SVMs are trained on 
subsamples of the original training data, with genes in set S 
as the input variable. Secondly, compute and normalize the 
weight vectors. By using the first equation, compute the 
ranking scores c, for genes in S. Next, find the gene with the 
smallest ranking score and eliminate that gene from the 
subset S. Lastly, update the list in gene set R. Fig. 3 shows 
the recursive procedure of MSVM-RFE. 
B. Improvement of SVM Using MSVM-RFE as Gene 
Selection 
The improvement of accuracy in SVM has been 
accomplished through the enhancement made in this work 
using MSVM-RFE as gene selection. The classifier package 
that implements SVM has been used in this research. This 
package is a compilation of function for the application and 
creation of highly optimized, robustly evaluated ensembles 
of SVM. It creates a highly optimized ensemble of Radial 
Basis Function (RBF) SVM classifiers. The flow of MSVM-
RFE is shown in Fig. 4 while Fig. 5 shows the enhancement 
of SVM using MSVM-RFE as gene selection. 
Firstly, preprocessing step needs to be performed to sort 
the dataset following the standard input dataset that should 
be formatted as a data frame. They consist of the row for 
each observation and column for each gene or feature. In 
MSVM-RFE, the first column should be the true class label 
whereas, for the SVM classifier, the data should be separated 
between the class and factor. Afterwards, the data will be 






Fig. 3  The recursive procedure of MSVM-RFE 
 
 
Fig. 4  The flow chart of MSVM-RFE 
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 Fig. 5  The flow work of enhancement. The shaded figure is the part of 
enhancement 
Then the MSVM-RFE is performed, where the first step is 
to set up the fold. This step has been repeated using 10-fold 
cross-validation on the training set for defining which 
remark are in which fold. Then, reformat the folds into a list 
that contains the test set indices for the fold. Then, by using 
this fold, perform gene ranking for all 10 training set. 
Indicate k=10 for the k-fold cross validation as the “multiple” 
part of MSVM-RFE, where the standard SVM-RFE is k=1. 
In this function, there are also has halved above parameter 
that allows us to cut the features or genes. This parameter 
will cut the features or genes in half each round, rather than 
one by one. In this work, this parameter has set 
halve.above=100 same as prior work. Hence, the genes will 
be cut in half each round until the number of genes fewer 
than 100 remains. The output from this step is a vector of 
genes or features, currently sorted from most to least useful.  
Lastly, the output of top feature for this step is the list of 
genes that are ordered by average rank across the 10 folds, 
where the lower the numbers in average rank, the better the 
result. 
In the SVM step, the dataset needs to be split into separate 
training and testing subsets using a bootstrapping approach 
combined with a heuristic optimization algorithm and 
parallel processing to minimize and reduce the computation 
time. Test set has been kept aside during the training process 
of the SVM model. Generally, the test set comprises of one-
third of the original samples. Then, bootstrapping is repeated 
until reasonable winning parameter combination is produced. 
The optimal parameters from the bootstrap step are utilized 
to train another classifier with the full train dataset and test 
the test dataset.  Because the data in the testing set already 
contains known values for the attribute for predict, it is easy 
to determine whether the model's guesses are correct and 
obtain the better accuracy. 
In this research, firstly the classifier that implements SVM 
classification has been run without gene selection of 
MSVM-RFE. The random genes in a dataset of varying 
numbers such as 10, 20, 30 and 40 until 100 genes have been 
tested. Then, SVM has been run with MSVM-RFE. By using 
the output of top features from MSVM-RFE result with 
varying number of genes such as 10, 20, 30 and 40 until 100 
have been undergoing the classifier package to perform 
SVM. The best subset of the gene is repeated the 
classification process for 20 times to obtain average of the 
accuracy. 
In this work, two types of datasets have been used, which 
are leukemia and lung datasets. The basic information of the 
dataset including the number of total genes, samples, and 
sizes of the class is shown in Table 1. The size of the class 
for leukemia dataset consists of 47 patients with acute 
lymphoblastic leukemia (ALL) and 25 patients with acute 
myeloid leukemia (AML). Meanwhile, the class size of lung 
dataset consists of 150 patients with adenocarcinoma 
(ADCA) and 31 patients with malignant pleural 
mesothelioma (MPM). 
TABLE I 
THE LIST OF THE DATASET 
Dataset Genes Samples Source 
Leukemia 7129 72 [7] 
Lung 12533 181 [6], [29], [23] 
III. RESULT AND DISCUSSION 
To evaluate the performance, the accuracy of the result is 
calculated according to [12].  
 
Accuracy  )*++,)-./	0+,12)-,1	13-3-*-3.	-,4-256	13-3 	× 100%        (5) 
 
 The results of leukemia dataset are compared with 
several methods which are standard SVM, enhanced SVM 
with MSVM-RFE as gene selection, random forest by 
Moorthy and Mohamad [30], [24], Random forest with 
MSVM-RFE [31], [25] and varSeIFE [32], [26].  The result 
based on accuracy and computational time. The result is 
tabulated in Table 2. The shaded row in the table indicates 
the best method based on highest accuracy and shortest time. 
The overall comparison of accuracy and computational 
time is presented to demonstrate the enhancement 
accomplished. Based on the result, the enhanced SVM with 
combine MSVM-RFE show an improvement in terms of 
better accuracy and lower computational time which can 
lead to lower computational cost.  
The random forest has many advantages such as good 
predictive performance even though most predictive genes 
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are noisy and can handle large input genes without gene 
deletion [32], [26]. However, the result of accuracy for 
enhanced SVM is higher than standard Random Forest and 
Random Forest with MSVM-RFE. The enhanced SVM 
achieve the highest result of accuracy with 0.986 and the 
shortest time with only 0.013 hours. The result of enhanced 
SVM followed by Random Forest with MSVM-RFE with 
0.949 for accuracy and 0.060 hour, standard Random Forest 
with 0.925 for accuracy and 0.013 hour, varSeIFR with 
0.911 for accuracy and 1.280 hour and lastly standard SVM 
with 0.881 for accuracy and 1.830 hour. Thus, based on this 
result it proved that MSVM-RFE is a power gene selection 
by improving classification method with a better result. 
 
TABLE II 
THE RESULT OF ACCURACY AND COMPUTATIONAL TIME FOR  
LEUKEMIA DATASET 
 
Meanwhile, the result of lung dataset had been compared 
with some methods which are standard SVM, enhanced 
SVM with MSVM-RFE as gene selection and C4.5 Decision 
Tree [33], [27] methods. The result based on accuracy is 
tabulated in Table 3. The shaded row in the table indicates 
the best method based on highest accuracy. All the findings 
show that the enhanced SVM outperforms the SVM without 
gene selection and C4.5 Decision Tree in terms of higher 
classification accuracy with 0.989. The result of enhancing 
SVM follow by C4.5 Decision Tree with 0.926 of accuracy 
and standard SVM with 0.920. Thus, it is proven that better 
accuracy can be gained by reducing the number of genes as 
the result of implementing gene selection. 
 
TABLE III 
THE RESULT OF ACCURACY FOR LUNG DATASET 
IV. CONCLUSIONS 
In this study, MSVM-RFE is implemented in the standard 
SVM as gene selection to handle a large number of genes in 
microarray data for identifying the small informative gene. 
Multiple SVM-RFE (MSVM-RFE) is an upgraded version 
of the original SVM-RFE. This method using a backward 
elimination procedure that eliminates the lowest weight of 
the gene, same like SVM-RFE. However, at each step, the 
computation of feature ranking score is based on the 
statistical analysis of weight vector of multiple linear SVMs 
that being trained on a subset of the training data.  The 
implementation of MSVM-RFE yields better and more 
accurate result compared to the SVM-RFE. MSVM-RFE is 
implemented to enhance the performance of SVM in terms 
of accuracy and computational time. The performance of the 
enhanced method has been compared with several methods 
such as Random Forest, Random Forest with MSVM-RFE, 
varSeIFE and C4.5 Decision Tree by using two different 
datasets of gene expression which are leukemia and lung 
cancer. All the findings show that the enhance SVM 
outperform the SVM without gene selection in terms of 
higher classification accuracy in both datasets and lower 
computational time in leukemia dataset. However, this 
research still has some limitations such as larger dataset are 
taking longer computational time, and all the datasets used 
require preprocessing before undergo the gene selection and 
classification processes. Therefore, there are many works 
that can be done in future to improve the results of the used 
method. Firstly, the result of this research can be compared 
with more performance measurement such as error rate, 
specificity, and sensitivity. Secondly, to implement, test and 
analyze the strength of MSVM-RFE with other classifier and 
compare the result with this research. Lastly, to add more 
type of dataset other than leukemia and lung data.   
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